Certificate in Psychedelic Assisted Therapy: Difference between revisions
From BurnZero
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
Created from intensive analysis of current Best Practice standards, including protocols created by MAPS and the REBUS model created at Imperial College London, this training certificate adheres to global best practices. | Created from intensive analysis of current Best Practice standards, including protocols created by MAPS and the REBUS model created at Imperial College London, this training certificate adheres to global best practices. | ||
'''References''' | |||
<references /> | |||
Revision as of 08:00, 9 August 2022
The provision of a supportive therapeutic setting prior to, during, and following drug administration is now the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. To fill this requirement, a variety of psychedelic-assisted psychotherapy (PAP) models have been developed. A recent analysis performed in June 2022[1], has found many lacking in rigour.
Created from intensive analysis of current Best Practice standards, including protocols created by MAPS and the REBUS model created at Imperial College London, this training certificate adheres to global best practices.
References
- ↑ The Psychotherapeutic Framing of Psychedelic Drug Administration. Front. Psychol., Sec. Psychology for Clinical Settings. Published: 02 June 2022, accessed on 9th August 2022 via: https://doi.org/10.3389/fpsyg.2022.866018